Clinical Trial Update: Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating antibacterial prophylaxis versus no prophylaxis in hematological malignancy patients prior to allogeneic HSCT; status not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allogeneic Hematopoietic Stem Cell Transplantation
• Hematological Malignancies

Drugs mentioned

• Imipenem

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Antibacterial Prophylaxis, Hematological Malignancies | Phase 2, Phase 3 | Status: UNKNOWN